184 related articles for article (PubMed ID: 12376337)
1. AICAR and phlorizin reverse the hypoglycemia-specific defect in glucagon secretion in the diabetic BB rat.
McCrimmon RJ; Evans ML; Jacob RJ; Fan X; Zhu Y; Shulman GI; Sherwin RS
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E1076-83. PubMed ID: 12376337
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes.
Fan X; Ding Y; Brown S; Zhou L; Shaw M; Vella MC; Cheng H; McNay EC; Sherwin RS; McCrimmon RJ
Am J Physiol Regul Integr Comp Physiol; 2009 Jun; 296(6):R1702-8. PubMed ID: 19357294
[TBL] [Abstract][Full Text] [Related]
3. Reversal of defective glucagon responses to hypoglycemia in insulin-dependent autoimmune diabetic BB rats.
Zhou H; Zhang T; Oseid E; Harmon J; Tonooka N; Robertson RP
Endocrinology; 2007 Jun; 148(6):2863-9. PubMed ID: 17347310
[TBL] [Abstract][Full Text] [Related]
4. Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Reversibility and stimulus specificity of the deficits.
Powell AM; Sherwin RS; Shulman GI
J Clin Invest; 1993 Dec; 92(6):2667-74. PubMed ID: 8254023
[TBL] [Abstract][Full Text] [Related]
5. Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus.
McCrimmon RJ; Fan X; Ding Y; Zhu W; Jacob RJ; Sherwin RS
Diabetes; 2004 Aug; 53(8):1953-8. PubMed ID: 15277372
[TBL] [Abstract][Full Text] [Related]
6. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
Popp DA; Shah SD; Cryer PE
J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
[TBL] [Abstract][Full Text] [Related]
7. Quantitative measurement of islet glucagon response to hypoglycemia by confocal fluorescence imaging in diabetic rats: effects of phlorizin treatment.
Rastogi KS; Cooper RL; Shi ZQ; Vranic M
Endocrine; 1997 Dec; 7(3):367-75. PubMed ID: 9657075
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia.
Bolli G; De Feo P; Perriello G; De Cosmo S; Compagnucci P; Santeusanio F; Brunetti P; Unger RH
J Clin Invest; 1984 Apr; 73(4):917-22. PubMed ID: 6368593
[TBL] [Abstract][Full Text] [Related]
9. Catecholamine responses and their interactions with other glucoregulatory hormones.
Vranic M; Gauthier C; Bilinski D; Wasserman D; El Tayeb K; Hetenyi G; Lickley HL
Am J Physiol; 1984 Aug; 247(2 Pt 1):E145-56. PubMed ID: 6147092
[TBL] [Abstract][Full Text] [Related]
10. Cardiac responses to insulin-induced hypoglycemia in nondiabetic and intensively treated type 1 diabetic patients.
Russell RR; Chyun D; Song S; Sherwin RS; Tamborlane WV; Lee FA; Pfeifer MA; Rife F; Wackers FJ; Young LH
Am J Physiol Endocrinol Metab; 2001 Nov; 281(5):E1029-36. PubMed ID: 11595660
[TBL] [Abstract][Full Text] [Related]
11. Increased responses of glucagon and glucose production to hypoglycemia with intraperitoneal versus subcutaneous insulin treatment.
Wan CK; Giacca A; Matsuhisa M; El-Bahrani B; Lam L; Rodgers C; Shi ZQ
Metabolism; 2000 Aug; 49(8):984-9. PubMed ID: 10954014
[TBL] [Abstract][Full Text] [Related]
12. Co-impairment of autonomic and glucagon responses to insulin-induced hypoglycemia in dogs with naturally occurring insulin-dependent diabetes mellitus.
Gilor C; Duesberg C; Elliott DA; Feldman EC; Mundinger TO; Taborsky GJ; Nelson RW; Havel PJ
Am J Physiol Endocrinol Metab; 2020 Dec; 319(6):E1074-E1083. PubMed ID: 33044845
[TBL] [Abstract][Full Text] [Related]
13. Time course of the defective alpha-cell response to hypoglycemia in diabetic BB rats.
Jacob RJ; Dziura J; Morgen JP; Shulman GI; Sherwin RS
Metabolism; 1996 Nov; 45(11):1422-6. PubMed ID: 8931649
[TBL] [Abstract][Full Text] [Related]
14. Portal venous 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion overcomes hyperinsulinemic suppression of endogenous glucose output.
Camacho RC; Pencek RR; Lacy DB; James FD; Donahue EP; Wasserman DH
Diabetes; 2005 Feb; 54(2):373-82. PubMed ID: 15677495
[TBL] [Abstract][Full Text] [Related]
15. Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.
Christopher M; Rantzau C; Chen ZP; Snow R; Kemp B; Alford FP
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1131-40. PubMed ID: 16772328
[TBL] [Abstract][Full Text] [Related]
16. Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats.
Borg MA; Borg WP; Tamborlane WV; Brines ML; Shulman GI; Sherwin RS
Diabetes; 1999 Mar; 48(3):584-7. PubMed ID: 10078560
[TBL] [Abstract][Full Text] [Related]
17. Phlorizin-induced normoglycemia partially restores glucoregulation in diabetic dogs.
Hetenyi G; Gauthier C; Byers M; Vranic M
Am J Physiol; 1989 Feb; 256(2 Pt 1):E277-83. PubMed ID: 2645787
[TBL] [Abstract][Full Text] [Related]
18. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin.
Camacho RC; Lacy DB; James FD; Donahue EP; Wasserman DH
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1039-43. PubMed ID: 16046457
[TBL] [Abstract][Full Text] [Related]
19. Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo.
Paranjape SA; Chan O; Zhu W; Horblitt AM; McNay EC; Cresswell JA; Bogan JS; McCrimmon RJ; Sherwin RS
Diabetes; 2010 Jun; 59(6):1521-7. PubMed ID: 20299468
[TBL] [Abstract][Full Text] [Related]
20. Brainstem dysfunction is provoked by a less pronounced hypoglycemic stimulus in diabetic BB rats.
Jacob RJ; Weber AB; Dziura J; Morgen J; Sherwin RS
Diabetes; 1995 Aug; 44(8):900-5. PubMed ID: 7621994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
